Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia

W. Deenik, B. van der Holt, GE Verhoef, W.M. Smit, M.J. Kersten, H.C. Kluin-Nelemans, L.F. Verdonck, A Ferrant, A.V. Schattenberg, J.J.W.M. Janssen, P. Sonneveld, K.M. van Marwijk, S. Wittebol, R. Willemze, P.W. Wijermans, PH Westveer, HB Beverloo, P. van der Valk, B. Lowenberg, G.J. OssenkoppeleJ.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2581-2588
JournalBlood
Volume111
Issue number5
DOIs
Publication statusPublished - 2008

Cite this

Deenik, W., van der Holt, B., Verhoef, GE., Smit, W. M., Kersten, M. J., Kluin-Nelemans, H. C., ... Cornelissen, J. J. (2008). Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia. Blood, 111(5), 2581-2588. https://doi.org/10.1182/blood-2007-08-107482